Status:
RECRUITING
MItral Regurgitation Risk Assessment and CLinical modElling
Lead Sponsor:
Sun Yat-sen University
Conditions:
Mitral Insufficiency
Mitral Regurgitation (MR)
Eligibility:
All Genders
18+ years
Brief Summary
Mitral regurgitation (MR) is a common valvular heart disease worldwide, and untreated severe MR is associated with an elevated risk of heart failure and mortality. According to causes, MR could be div...
Eligibility Criteria
Inclusion
- Patients diagnosed with ≥ moderate mitral regurgitation during hospitalization.
- Aged over 18 yrs.
Exclusion
- Patients unable to provide written consent.
Key Trial Info
Start Date :
June 15 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 15 2030
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06876883
Start Date
June 15 2016
End Date
June 15 2030
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Sun Yat-sen Univerity
Guangzhou, Guangdong, China, 510000